Molecular Mechanism and Pharmacological Target of Neuroprotection
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".
Deadline for manuscript submissions: closed (20 April 2026) | Viewed by 603
Special Issue Editor
Special Issue Information
Dear Colleagues,
Neurodegeneration is caused by the progressive loss of neurons and can affect the central and peripheral nervous systems of millions of people worldwide. Many of these disorders can be caused by the alteration of genetic and molecular factors. These defects can induce a progressive decline in memory, locomotion, sensory perception, etc. Although considerable discoveries have been achieved by researchers worldwide, the pathogenesis of neurodegeneration is still unclear, and no pharmacological strategies or drugs can stop or alleviate progressive neurodegeneration in the brains and spinal cords of affected patients.
This Special Issue will focus on the molecular mechanisms and pharmacological targets of neuroprotection. Novel findings on key pharmacological targets and underlying molecular mechanisms will help us to develop new therapeutic strategies and agents to treat neurodegeneration. In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:
- Use of in vitro or in vivo models to identify new pharmacological neuroprotectors;
- Use and/or generation of animal models to study neurodegeneration;
- Identifying specific molecular targets to induce neural repair.
Dr. Pietro Cacialli
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurodegeneration
- animal model
- brain regeneration
- pharmacological drug
- molecular analysis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
